We do not recommend the use of KIRA6 as an MC inhibitor in patients with allergies or other inflammatory diseases involving MCs, since the combined inhibitory activity against SFKs, KIT [16], and the ubiquitous UPR sensor IRE1α could cause detrimental side effects. The gene discussed is KIT; the disease is allergic disease.